Posters & Publications

Third Quarter 2026 Earnings Conference Call  Click Here

To view our PMN310 Scientific and Clinical Update (November 2026)   Click Here

Years of Research at Your Fingertips

ProMIS Neurosciences’ publications and posters provide ample background on our research surrounding neurodegenerative diseases.

Filter By:

PMN310 | Amyloid-Beta

AD/PD 2023 Poster - Ability to selectively target toxic brain oligomers despite competing monomers and plaque

View
PMN442 | Alpha-Synuclein

Rational Generation of Monoclonal Antibodies Selective for Pathogenic Forms of Alpha-Synuclein

View
PMN310 | Amyloid-Beta

A Rationally Designed Humanized Antibody selective for Amyloid Beta oligomers in Alzheimer’s

View
PMN310 | Amyloid-Beta

Supplemental Section - A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease

View
PMN310 | Amyloid-Beta

AAIC 2022 Poster - Distinguishing between amyloid-beta-directed antibodies: Ability of PMN310 to target toxic oligomers despite competing species

View
Discovery

AAN 2022 Poster - RACK1 Knockdown Alleviates TDP-43 Associated Global Translational Suppression in vitro, and Neurodegeneration in vivo

View
PMN310 | Amyloid-Beta

NDD 2022 Presentation - Selective Antibody Targeting of Pathogenic Proteins: maximizing target engagement, minimizing target distraction

View
PMN311 | AD Vaccine

AD/PD 2022 Presentation - Optimizing vaccine design for Alzheimer’s disease: Selective targeting of computationally-derived conformational B cell epitopes of soluble amyloid-beta toxic oligomers

View
PMN267 | TDP-43

AAIC 2021 Presentation - Selective Targeting of Intracellular Misfolded, Pathogenic TDP-43 with Rationally Designed Intrabodies

View
EpiSelect™ Platform

AAIC 2021 Poster - Conformational epitopes exposed on misfolded toxic forms of amyloid-beta, tau and alpha-synuclein directly contribute to their seeding activity

View
PMN442 | Alpha-Synuclein

AAN 2020 Presentation - Achieving an optimal profile for immunotherapy of alpha-synucleinopathies: Rational generation of monoclonal antibodies selective for pathogenic forms of alpha-synuclein

View
PMN267 | TDP-43

AAN 2020 Presentation - Generation of antibodies selective for misfolded disease-associated TDP-43

View